Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933. (Q48100770)
scientific article
Language:
Current Data About Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.
(P31) (Q13442814)
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

(P50) (Q110644166)
(P1545) 5
(P1932) G Storme
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

(P304) 3143-3149
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

(P407) (Q1860)

(P433) 10
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

(P478) 17
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

(P577) Friday, October 1, 1999
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

(P921) (Q180507)

(Q192423)
(P887)

(Q282142)
(P887)

(P1433) (Q400292)
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

(P1476) "Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933." (language: en)
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

(P2093) R Miralbell
(P1545) 1
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

F Mornex
(P1545) 2
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

R Greiner
(P1545) 3
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

M Bolla
(P1545) 4
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

M Hulshof
(P1545) 6
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

J Bernier
(P1545) 7
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

J Denekamp
(P1545) 8
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

A M Rojas
(P1545) 9
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

M Pierart
(P1545) 10
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

M van Glabbeke
(P1545) 11
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

R O Mirimanoff
(P1545) 12
(P248)
(P698) 10506611
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/10506611

other details
description scientific article

External Links
(P356) 10.1200/JCO.1999.17.10.3143
(P698) 10506611